Pillstats
Rx only · Injection, Solution · Intramuscular

Hydroxocobalamin

Hydroxocobalamin Acetate

1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US1 NDCs
1 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCB03BA03
RxCUI (US)5514
US makers1 labelers
Packages1
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 1 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.236$0.472$0.708$0.944Dec 2025Feb 2026Mar 2026
$0.814
Latest avg · Mar 18, 2026
-1%
Since Dec 17, 2025
1
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

2094196288372025 Q12025 Q22025 Q32025 Q42026 Q1
172
Rx · 2026 Q1
2.0K
Units dispensed
-72%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it1 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Actavis Pharma, Inc.unknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Nov 4, 2024
    SHORTAGEDrug shortage: Hydroxocobalamin Injection (Teva Pharmaceuticals USA, Inc.)

    Hydroxocobalamin Injection — reported in shortage by Teva Pharmaceuticals USA, Inc.. Therapeutic category: Other.